Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Cardinal Health Has Acquired Six China Drug Distributors for $120 Million

publication date: Feb 6, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Cardinal Health, a major US drug distributor, says it has spent $120 million to acquire six China drug distributors during the last year, paying less than $30 million for each one.  Cardinal’s CFO Jeff Henderson said the goal with each transaction was not revenue volume but greater geographical reach. The acquisition targets were not named. In 2010, Cardinal made a dramatic entry in China’s drug distribution sector by purchasing Zuellig China for $458 million. More details....

Stock Symbol: (NYSE: CAH)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors